PNG version of QUB Shield - Red

NICR_Logo_215W_84H

Breast/in-situ breast

Cardwell CR, Pottegård A, Vaes E, Garmo H, Murray LJ, Brown C, Vissers PAJ, O’Rorke M, Visvanathan K, Cronin-Fenton D, De Schutter H, Lambe M, Powe DG, van Herk-Sukel MPP, Gavin A, Friis S, Sharp L, Bennett K. Propranolol and survival from breast cancer: A pooled analysis of European breast cancer cohorts. Breast Cancer Res. 2016; 18: 119. Published online 2016 Dec 1. doi: 10.1186/s13058-016-0782-5.

Allemani C, Minicozzi P, Berrino F, Bastiaannet E, Gavin A, Galceran J, Ameijide A, Siesling S, Mangone L, Ardanaz E, Hedelin G, Mateos A, Micheli A, Sant M and the EUROCARE Working Group.  Predictions of survival up to 10 years after diagnosis for European women with breast cancer in 2000-2002. Int J Cancer. 2013 May 15;132(10):2404-12. doi: 10.1002/ijc.27895. Epub 2012 Nov 7

Carney P, Gavin A, O'Neill C. The role of private care in the interval between diagnosis and treatment of breast cancer in Northern Ireland: an analysis of Registry data. BJM, 3 December 2013; doi:10.1136/bmjopen-2013-004074

Walters S, Maringe C, Butler J, Rachet B, Barrett-Lee P, Bergh J, Boyages J, Christiansen P, Lee M, Wärnberg F, Allemani C, Engholm G, Fornander T, Gjerstorff ML, Johannesen TB, Lawrence G, McGahan CE, Middleton R, Steward J, Tracey E, Turner D, Richards MA, Coleman MP and The ICBP Module 1 Working Group.  Breast cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK, 2000-2007: a population-based study.  British Journal of Cancer, 28 February 2013; doi: 10.1038/bjc.2013.6

Glover JA, Bannon FJ, Hughes CM, Cantwell MM, Comber H, Gavin A, Deady S, Murray LJ. Increased diagnosis and detection rates of carcinoma in situ of the breast. Breast Cancer Research and Treatment Journal, February 2012, doi.org/10.1007/s10549-012-1975-y

Autier P, Boniol M, Gavin AT and Vatten L.  Breast cancer mortality in neighbouring European countries with different levels of breast screening but similar access to treatment: An analysis of WHO mortality database.  British Medical Journal, July 2011, doi: 10.1136/bmj.d4411.

Autier P, Boniol M, Middleton R, Dore FJ, Hery C, Zheng T, Gavin A.  Advanced breast cancer incidence following population based mammographic screening.  The Annals of Oncology, January 2011, doi: 10.1093/annonc/mdq633.

Kinnear H, Connolly S, Rosato M, Hall C, Mairs A, O’Reilly D.  Are caregiving responsibilities associated with non-attendance at breast screening?  BMC Public Health, December 2010, doi:10.1186/1471-2458-10-749.

Autier P, Boniol M, LaVecchia C, Vatten L, Gavin AT, Héry C, Haenue M.  Disparities in breast cancer mortality trends between 30 European countries: retrospective trend analysis of WHO mortality database. British Medical Journal, August 2010,  doi: 10.1136/bmj.c3620.

Walsh PM, McCarron PG, Middleton RJ, Comber H Gavin AT, Murray L.  Influence of mammographic screening on trends in breast-conserving surgery in Ireland.  European Journal of Cancer Prevention, April 2006, doi: 10.1097/01.cej.0000180668.96710.47.

Monaghan P, Murray L, Donnelly M, McCarron P, Spence R, Gavin A.  Breast cancer services - a population based study of service reorganisation .  Journal of Public Health, online March 2005, doi:10.1093/pubmed/fdi003.